NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $15.68 +0.03 (+0.19%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$15.46▼$15.8850-Day Range$15.43▼$19.0652-Week Range$15.39▼$39.25Volume731,315 shsAverage Volume1.38 million shsMarket Capitalization$1.32 billionP/E Ratio7.43Dividend YieldN/APrice Target$22.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends Get InMode alerts: Email Address InMode MarketRank™ Stock AnalysisAnalyst RatingHold2.17 Rating ScoreUpside/Downside42.9% Upside$22.40 Price TargetShort InterestHealthy7.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.88Based on 7 Articles This WeekInsider TradingN/AProj. Earnings Growth17.79%From $1.63 to $1.92 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.48 out of 5 starsMedical Sector254th out of 910 stocksElectromedical Equipment Industry6th out of 22 stocks 3.1 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 1 buy rating, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 4 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.42% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in InMode has recently decreased by 10.62%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 2.7 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for InMode this week, compared to 6 articles on an average week.Search InterestOnly 8 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 17.79% in the coming year, from $1.63 to $1.92 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 7.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.71.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 7.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.06.Price to Book Value per Share RatioInMode has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InMode's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About InMode Stock (NASDAQ:INMD)InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More INMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INMD Stock News HeadlinesSeptember 6 at 5:12 AM | seekingalpha.comInMode Stock: An Inverse Bubble Caused By Short-Term TroubleSeptember 4 at 8:30 AM | prnewswire.comInMode to Present at 2024 Baird Global Healthcare ConferenceSeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.September 2, 2024 | finance.yahoo.comInMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts?August 31, 2024 | americanbankingnews.comInMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by BrokeragesAugust 18, 2024 | finance.yahoo.comINMD Sep 2024 10.000 put (INMD240920P00010000)August 14, 2024 | msn.comInMode Ltd. (INMD): Challenges and Insights in the Beauty IndustryAugust 13, 2024 | insidermonkey.com10 Stocks That Will Change the WorldSeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.August 8, 2024 | finance.yahoo.comSome Investors May Be Willing To Look Past InMode's (NASDAQ:INMD) Soft EarningsAugust 6, 2024 | prnewswire.comInMode to Present at Upcoming Investor ConferencesAugust 3, 2024 | finance.yahoo.comInMode Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than ExpectedAugust 2, 2024 | msn.comInMode Ltd. (NASDAQ:INMD) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | markets.businessinsider.comInMode’s Hold Rating Amid Decelerating Growth and Economic HeadwindsAugust 1, 2024 | msn.comInMode (INMD) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | fool.comInMode Ltd. Revenue, Profit PlungeAugust 1, 2024 | finance.yahoo.comInvesting in InMode (NASDAQ:INMD) five years ago would have delivered you a 167% gainAugust 1, 2024 | prnewswire.comInMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6MSee More Headlines Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/01/2024Today9/07/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees480Year Founded2008Price Target and Rating Average Stock Price Target$22.40 High Stock Price Target$29.00 Low Stock Price Target$16.00 Potential Upside/Downside+42.9%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$2.11 Trailing P/E Ratio7.43 Forward P/E Ratio9.62 P/E GrowthN/ANet Income$197.92 million Net Margins35.81% Pretax MarginN/A Return on Equity21.00% Return on Assets18.90% Debt Debt-to-Equity RatioN/A Current Ratio8.63 Quick Ratio8.09 Sales & Book Value Annual Sales$416.63 million Price / Sales3.16 Cash Flow$2.07 per share Price / Cash Flow7.56 Book Value$8.94 per share Price / Book1.75Miscellaneous Outstanding Shares83,982,000Free Float78,170,000Market Cap$1.32 billion OptionableOptionable Beta2.17 Social Links Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Yair Malca (Age 46)Chief Financial Officer Comp: $581kMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 41)President of North America Comp: $3.49MMr. Moshe Mizrahy (Age 71)Chairman & CEO Comp: $216kMr. Alon YaariVice President of OperationsDr. Michael Kreindel (Age 56)CTO & Director Comp: $221kDr. Spero Theodorou M.D. (Age 52)Chief Medical Officer Comp: $1.84MMore ExecutivesKey CompetitorsNatus MedicalNASDAQ:NTUSOutset MedicalNASDAQ:OMCuteraNASDAQ:CUTRPROCEPT BioRoboticsNASDAQ:PRCTAxonicsNASDAQ:AXNXView All CompetitorsInstitutional OwnershipSystematic Financial Management LPBought 222,532 shares on 8/16/2024Ownership: 1.032%Disciplined Growth Investors Inc. MNBought 22,427 shares on 8/16/2024Ownership: 0.958%Quarry LPSold 934 shares on 8/16/2024Ownership: 0.002%The Manufacturers Life Insurance Company Sold 517,980 shares on 8/15/2024Ownership: 0.702%Mackenzie Financial CorpBought 21,165 shares on 8/15/2024Ownership: 0.129%View All Institutional Transactions INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $22.24 on January 1st, 2024. Since then, INMD stock has decreased by 29.5% and is now trading at $15.68. View the best growth stocks for 2024 here. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) posted its quarterly earnings data on Thursday, August, 1st. The healthcare company reported $0.34 earnings per share for the quarter, missing analysts' consensus estimates of $0.38 by $0.04. The company's revenue was down 24.6% compared to the same quarter last year. When did InMode's stock split? InMode's stock split before market open on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. Does InMode have any subsidiaries? InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? Top institutional shareholders of InMode include Renaissance Technologies LLC (2.46%), Doma Perpetual Capital Management LLC (2.39%), LSV Asset Management (2.21%) and Boston Trust Walden Corp (1.72%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD) and Block (SQ). This page (NASDAQ:INMD) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
